Cas:69808-32-8 (5E)-1-butyl-5-[(4-chlorophenyl)hydrazinylidene]-4-methyl-2,6-dioxopyridine-3-carbonitrile manufacturer & supplier

Chemical Name:(5E)-1-butyl-5-[(4-chlorophenyl)hydrazinylidene]-4-methyl-2,6-dioxopyridine-3-carbonitrile

CAS.NO:69808-32-8

Synonyms:(5E)-1-butyl-5-[(4-chlorophenyl)hydrazinylidene]-4-methyl-2,6-dioxopyridine-3-carbonitrile

Molecular Formula:C₁₇H₁₇ClN₄O₂

Molecular Weight:344.79500

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:467ºC at 760 mmHg

Density:1.28g/cm3

Index of Refraction:1.615

PSA:85.56000

Exact Mass:344.10400

LogP:3.12778

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like (5E)-1-butyl-5-[(4-chlorophenyl)hydrazinylidene]-4-methyl-2,6-dioxopyridine-3-carbonitrile chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(5E)-1-butyl-5-[(4-chlorophenyl)hydrazinylidene]-4-methyl-2,6-dioxopyridine-3-carbonitrile physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(5E)-1-butyl-5-[(4-chlorophenyl)hydrazinylidene]-4-methyl-2,6-dioxopyridine-3-carbonitrile Use and application,(5E)-1-butyl-5-[(4-chlorophenyl)hydrazinylidene]-4-methyl-2,6-dioxopyridine-3-carbonitrile technical grade,usp/ep/jp grade.

Related News: On the basis of achieving low-cost and high-quality processes, production capacity will become the core driving force for API companies to break through sales bottlenecks. (5E)-1-butyl-5-[(4-chlorophenyl)hydrazinylidene]-4-methyl-2,6-dioxopyridine-3-carbonitrile manufacturer Steven M. Fruchtman, M.D., President and Chief Executive Officer of Onconova, added ��The rigosertib Pre-approval Access Program is a key strategic initiative for Onconova. (5E)-1-butyl-5-[(4-chlorophenyl)hydrazinylidene]-4-methyl-2,6-dioxopyridine-3-carbonitrile supplier Inceptua is a pharmaceutical company and service partner spanning throughout the product lifecycle �C from comparator sourcing for clinical trials, through early access programs to licensing and commercialization for products. (5E)-1-butyl-5-[(4-chlorophenyl)hydrazinylidene]-4-methyl-2,6-dioxopyridine-3-carbonitrile vendor South Korea and Japan are barring noncitizens who traveled recently to Hubei, the province at the center of the outbreak. (5E)-1-butyl-5-[(4-chlorophenyl)hydrazinylidene]-4-methyl-2,6-dioxopyridine-3-carbonitrile factory On the basis of achieving low-cost and high-quality processes, production capacity will become the core driving force for API companies to break through sales bottlenecks.